<code id='C3F3F20696'></code><style id='C3F3F20696'></style>
    • <acronym id='C3F3F20696'></acronym>
      <center id='C3F3F20696'><center id='C3F3F20696'><tfoot id='C3F3F20696'></tfoot></center><abbr id='C3F3F20696'><dir id='C3F3F20696'><tfoot id='C3F3F20696'></tfoot><noframes id='C3F3F20696'>

    • <optgroup id='C3F3F20696'><strike id='C3F3F20696'><sup id='C3F3F20696'></sup></strike><code id='C3F3F20696'></code></optgroup>
        1. <b id='C3F3F20696'><label id='C3F3F20696'><select id='C3F3F20696'><dt id='C3F3F20696'><span id='C3F3F20696'></span></dt></select></label></b><u id='C3F3F20696'></u>
          <i id='C3F3F20696'><strike id='C3F3F20696'><tt id='C3F3F20696'><pre id='C3F3F20696'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:29

          How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

          advertisement

          For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          Wikipedia

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          New documents shed light on MD Anderson Cancer Institute feud
          New documents shed light on MD Anderson Cancer Institute feud

          AdobeEarlylastyear,MDAndersonCancerCenterleadershiphadaproblemontheirhands:acontentiousdisputebetwee

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

          RubyWallauforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne